Your browser doesn't support javascript.
loading
Neuropeptide VGF-Derived Peptide LQEQ-19 has Neuroprotective Effects in an In Vitro Model of Amyotrophic Lateral Sclerosis.
Noda, Y; Motoyama, S; Nakamura, S; Shimazawa, M; Hara, H.
Affiliation
  • Noda Y; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.
  • Motoyama S; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.
  • Nakamura S; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.
  • Shimazawa M; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan.
  • Hara H; Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, 1-25-4 Daigaku-nishi, Gifu, 501-1196, Japan. hidehara@gifu-pu.ac.jp.
Neurochem Res ; 44(4): 897-904, 2019 Apr.
Article in En | MEDLINE | ID: mdl-30656593

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Neuropeptides / Neuroprotective Agents / Amyotrophic Lateral Sclerosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Neurochem Res Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Neuropeptides / Neuroprotective Agents / Amyotrophic Lateral Sclerosis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Neurochem Res Year: 2019 Document type: Article